Evolution of Brain Glucose Metabolic Abnormalities in Children With Epilepsy and SCN1A Gene Variants

Area of Science:

• Neuroscience
• Medical Imaging
• Genetics

Background:

• Epilepsy associated with SCN1A variants often presents with drug-refractory seizures.
• Standard MRI may not reveal abnormalities in these cases.
• Longitudinal metabolic changes in SCN1A-related epilepsy are not well-characterized.

Purpose of the Study:

• To investigate the longitudinal changes in cerebral glucose metabolism in children with SCN1A variants and epilepsy.
• To determine if FDG-PET can identify characteristic metabolic patterns.
• To explore the potential of FDG-PET as a biomarker for disease progression.

Main Methods:

• Three children with SCN1A variants and refractory epilepsy underwent FDG-PET scans at two time points: early childhood (6 months-1 year) and later childhood (3.5-5.5 years).
• FDG uptake was quantified and compared to age- and gender-matched controls.
• Regional metabolic patterns were analyzed across different cortical areas.

Main Results:

• At baseline, children with SCN1A variants showed normal brain glucose metabolism, similar to controls.
• At follow-up, significant bilateral cortical hypometabolism was observed, particularly in the frontal, parietal, and temporal lobes.
• Milder hypometabolism was noted in the occipital cortex.

Conclusions:

• Children with epilepsy and SCN1A variants exhibit normal glucose metabolism in infancy.
• Progressive bilateral cortical hypometabolism develops by early childhood, with specific regional predilections.
• This distinct metabolic pattern may serve as a characteristic biomarker for SCN1A-related epilepsy and aid in monitoring treatment response.